HK1243764A1 - 用於富集循環腫瘤dna的方法 - Google Patents
用於富集循環腫瘤dna的方法Info
- Publication number
- HK1243764A1 HK1243764A1 HK18103101.0A HK18103101A HK1243764A1 HK 1243764 A1 HK1243764 A1 HK 1243764A1 HK 18103101 A HK18103101 A HK 18103101A HK 1243764 A1 HK1243764 A1 HK 1243764A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- enrichment
- circulating tumor
- tumor dna
- dna
- circulating
- Prior art date
Links
- 206010028980 Neoplasm Diseases 0.000 title 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6875—Nucleoproteins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/1003—Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N27/00—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
- G01N27/62—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating the ionisation of gases, e.g. aerosols; by investigating electric discharges, e.g. emission of cathode
- G01N27/622—Ion mobility spectrometry
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2560/00—Chemical aspects of mass spectrometric analysis of biological material
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/70—Mechanisms involved in disease identification
- G01N2800/7023—(Hyper)proliferation
- G01N2800/7028—Cancer
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Physics & Mathematics (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Analytical Chemistry (AREA)
- Biotechnology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Microbiology (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Cell Biology (AREA)
- Medicinal Chemistry (AREA)
- Food Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Organic Chemistry (AREA)
- Crystallography & Structural Chemistry (AREA)
- Electrochemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Plant Pathology (AREA)
- Biophysics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1419225.6A GB201419225D0 (en) | 2014-10-29 | 2014-10-29 | Method for the enrichment of circulating tumor DNA |
| GB201419299A GB201419299D0 (en) | 2014-10-30 | 2014-10-30 | Method for the enrichment of circulating tumour DNA |
| PCT/GB2015/053238 WO2016067029A1 (en) | 2014-10-29 | 2015-10-29 | Method for the enrichment of circulating tumor dna |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HK1243764A1 true HK1243764A1 (zh) | 2018-07-20 |
Family
ID=54427791
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK18103101.0A HK1243764A1 (zh) | 2014-10-29 | 2018-03-05 | 用於富集循環腫瘤dna的方法 |
Country Status (14)
| Country | Link |
|---|---|
| US (2) | US20180024141A1 (zh) |
| EP (2) | EP3809140A1 (zh) |
| JP (1) | JP6721599B2 (zh) |
| CN (2) | CN111505305B (zh) |
| AU (1) | AU2015340378B2 (zh) |
| CA (1) | CA2965752C (zh) |
| DK (1) | DK3213084T4 (zh) |
| ES (1) | ES2839973T3 (zh) |
| HK (1) | HK1243764A1 (zh) |
| IL (1) | IL251896A0 (zh) |
| NZ (1) | NZ731116A (zh) |
| PL (1) | PL3213084T3 (zh) |
| SG (2) | SG10201903822XA (zh) |
| WO (1) | WO2016067029A1 (zh) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2820129A1 (en) | 2012-03-02 | 2015-01-07 | Sequenom, Inc. | Methods and processes for non-invasive assessment of genetic variations |
| WO2014168711A1 (en) | 2013-03-13 | 2014-10-16 | Sequenom, Inc. | Primers for dna methylation analysis |
| US11365447B2 (en) | 2014-03-13 | 2022-06-21 | Sequenom, Inc. | Methods and processes for non-invasive assessment of genetic variations |
| CN106544341A (zh) * | 2017-01-17 | 2017-03-29 | 上海亿康医学检验所有限公司 | 高效检测样本中的ctDNA的方法 |
| CN117138146A (zh) | 2017-09-18 | 2023-12-01 | 圣特萨斯股份公司 | 用于针对循环无细胞dna纯化血液的方法和装置 |
| CN109932224A (zh) * | 2017-12-18 | 2019-06-25 | 中国科学院大连化学物理研究所 | 一种富集提取循环肿瘤dna的方法 |
| EP3765638A2 (en) * | 2018-03-13 | 2021-01-20 | Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. | Diagnostic use of cell free dna chromatin immunoprecipitation |
| GB201818963D0 (en) | 2018-11-21 | 2019-01-09 | Belgian Volition Sprl | Methof for the detection of prostate cancer |
| GB201818965D0 (en) | 2018-11-21 | 2019-01-09 | Belgian Volition Sprl | Method for the detection of colorectal cancer |
| CN109841265B (zh) * | 2019-02-22 | 2021-09-21 | 清华大学 | 使用片段化模式确定血浆游离核酸分子组织来源的方法和系统及应用 |
| GB201906199D0 (en) | 2019-05-02 | 2019-06-19 | Belgian Volition Sprl | Method for the detection of cancer |
| GB201906201D0 (en) | 2019-05-02 | 2019-06-19 | Belgian Voltion Sprl | Method for the detection of protate cancer |
| WO2021064463A1 (en) * | 2019-10-04 | 2021-04-08 | Santersus Ag | Method for isolating and analyzing cell free dna |
| JP7349104B2 (ja) * | 2019-11-13 | 2023-09-22 | 株式会社島津製作所 | ベロ毒素の検出方法 |
| CA3163181A1 (en) | 2019-12-02 | 2021-06-10 | Belgian Volition Srl | Use of cell free nucleosomes as biomarkers |
| GB202117799D0 (en) | 2021-12-09 | 2022-01-26 | Belgian Volition Srl | Method for the detection of blood cancer |
| WO2023122623A1 (en) * | 2021-12-21 | 2023-06-29 | Guardant Health, Inc. | Methods and systems for combinatorial chromatin-ip sequencing |
| WO2023170298A1 (en) | 2022-03-11 | 2023-09-14 | Belgian Volition Srl | Differential diagnosis method |
| WO2024042210A1 (en) * | 2022-08-25 | 2024-02-29 | Belgian Volition Srl | Method for measuring cell free chromatin |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0319376D0 (en) | 2003-08-18 | 2003-09-17 | Chroma Therapeutics Ltd | Histone modification detection |
| US20060115482A1 (en) * | 2004-04-27 | 2006-06-01 | The Regents Of The University Of California | Modifications of histone proteins as indicators of cell proliferation and differentiation |
| WO2007121276A2 (en) * | 2006-04-12 | 2007-10-25 | Biocept, Inc. | Enrichment of circulating fetal dna |
| EP2062912A1 (en) * | 2007-11-26 | 2009-05-27 | Koninklijke Philips Electronics N.V. | Selective enrichment of post-translationally modified proteins and/or peptides |
| US20100240054A1 (en) * | 2008-09-22 | 2010-09-23 | Biocept, Inc. | Identification and isolation of fetal cells and nucleic acid |
| EP2419737A4 (en) * | 2009-04-14 | 2013-02-13 | Univ California | HISTON MODIFYING PATTERN FOR CLINICAL DIAGNOSIS AND FORECASTING CANCER |
| US20140213475A1 (en) * | 2011-07-14 | 2014-07-31 | University Of Massachusetts | Methods of diagnosing cancer using epigenetic biomarkers |
| GB201115095D0 (en) | 2011-09-01 | 2011-10-19 | Singapore Volition Pte Ltd | Method for detecting nucleosomes containing nucleotides |
| GB201115098D0 (en) | 2011-09-01 | 2011-10-19 | Belgian Volition Sa | Method for detecting nucleosomes containing histone variants |
| CA2854255C (en) | 2011-11-21 | 2022-01-25 | The Royal Institution For The Advancement Of Learning / Mcgill University | Mutations of histone proteins associated with proliferative disorders |
| ES2649404T3 (es) * | 2011-12-07 | 2018-01-11 | Belgian Volition Sprl | Procedimiento para detectar aductos de nucleosomas |
| EP2820129A1 (en) * | 2012-03-02 | 2015-01-07 | Sequenom, Inc. | Methods and processes for non-invasive assessment of genetic variations |
| US9388213B2 (en) * | 2012-09-10 | 2016-07-12 | The Rockefeller University | Polycomb repressive complex 2 (PRC2) inhibitors and uses thereof |
-
2015
- 2015-10-29 EP EP20203154.8A patent/EP3809140A1/en active Pending
- 2015-10-29 CN CN202010018617.1A patent/CN111505305B/zh active Active
- 2015-10-29 PL PL15790214T patent/PL3213084T3/pl unknown
- 2015-10-29 JP JP2017542357A patent/JP6721599B2/ja active Active
- 2015-10-29 WO PCT/GB2015/053238 patent/WO2016067029A1/en active Application Filing
- 2015-10-29 EP EP15790214.9A patent/EP3213084B2/en active Active
- 2015-10-29 AU AU2015340378A patent/AU2015340378B2/en active Active
- 2015-10-29 CA CA2965752A patent/CA2965752C/en active Active
- 2015-10-29 NZ NZ731116A patent/NZ731116A/en unknown
- 2015-10-29 SG SG10201903822XA patent/SG10201903822XA/en unknown
- 2015-10-29 SG SG11201702978VA patent/SG11201702978VA/en unknown
- 2015-10-29 DK DK15790214.9T patent/DK3213084T4/da active
- 2015-10-29 US US15/523,280 patent/US20180024141A1/en not_active Abandoned
- 2015-10-29 ES ES15790214T patent/ES2839973T3/es active Active
- 2015-10-29 CN CN201580058989.4A patent/CN107209190B/zh active Active
-
2017
- 2017-04-25 IL IL251896A patent/IL251896A0/en active IP Right Grant
-
2018
- 2018-03-05 HK HK18103101.0A patent/HK1243764A1/zh active IP Right Maintenance
-
2022
- 2022-06-07 US US17/834,701 patent/US20220334128A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| US20180024141A1 (en) | 2018-01-25 |
| NZ731116A (en) | 2024-03-22 |
| JP6721599B2 (ja) | 2020-07-15 |
| CA2965752C (en) | 2024-04-02 |
| IL251896A0 (en) | 2017-06-29 |
| DK3213084T4 (da) | 2024-03-18 |
| CN111505305B (zh) | 2023-10-17 |
| AU2015340378B2 (en) | 2021-08-12 |
| CN107209190A (zh) | 2017-09-26 |
| PL3213084T3 (pl) | 2021-07-26 |
| WO2016067029A1 (en) | 2016-05-06 |
| ES2839973T3 (es) | 2021-07-06 |
| DK3213084T3 (da) | 2021-01-18 |
| SG11201702978VA (en) | 2017-05-30 |
| US20220334128A1 (en) | 2022-10-20 |
| EP3213084B2 (en) | 2023-12-13 |
| CN107209190B (zh) | 2021-07-16 |
| CA2965752A1 (en) | 2016-05-06 |
| EP3213084B1 (en) | 2020-11-25 |
| AU2015340378A1 (en) | 2017-05-11 |
| JP2017534300A (ja) | 2017-11-24 |
| EP3809140A1 (en) | 2021-04-21 |
| EP3213084A1 (en) | 2017-09-06 |
| CN111505305A (zh) | 2020-08-07 |
| SG10201903822XA (en) | 2019-05-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1243764A1 (zh) | 用於富集循環腫瘤dna的方法 | |
| HK1257775A1 (zh) | 四價多特異性抗體 | |
| PT3334841T (pt) | Métodos para estudar ácidos nucleicos | |
| SG10201913629VA (en) | Artificial nucleic acid molecules | |
| IL247273B (en) | Multispecific antibodies | |
| IL279627A (en) | A method for treating depression | |
| SG11201704681QA (en) | Artificial nucleic acid molecules | |
| SG10201913409VA (en) | Methods for solid tumor treatment | |
| SG11201701723XA (en) | Methods of treating liver disease | |
| GB201414823D0 (en) | Multispecific antibodies | |
| GB201421096D0 (en) | Genome editing methods | |
| HK1244217A1 (zh) | 用於治療蛋白質病的方法 | |
| LT3094731T (lt) | Sacharidais modifikuotos nukleorūgšties molekulės | |
| GB201408841D0 (en) | Nucleic acid processing | |
| GB201418892D0 (en) | DNA editing | |
| SG11201609754QA (en) | Sequencing process | |
| GB201405226D0 (en) | Nucleic acid preparation method | |
| PL3142837T3 (pl) | Sposób modyfikacji drewna | |
| GB201420428D0 (en) | Methods for nucleic acid isolation | |
| GB201415674D0 (en) | Nucleic acid analysis | |
| IL241974A0 (en) | Process for making erlotinib | |
| GB201419225D0 (en) | Method for the enrichment of circulating tumor DNA | |
| GB201419299D0 (en) | Method for the enrichment of circulating tumour DNA | |
| HK1256371A1 (zh) | 用於治療腫瘤的方法 | |
| GB201602038D0 (en) | Methods for nucleic acid enrichment |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AM43 | Amendment of standard patent following opposition or revocation proceedings in the designated patent office (acc. sect 43 patent ordinance) |